Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Maryam Afkarian"'
Autor:
Thomas Hu, Mayar Allam, Shuangyi Cai, Walter Henderson, Brian Yueh, Aybuke Garipcan, Anton V. Ievlev, Maryam Afkarian, Semir Beyaz, Ahmet F. Coskun
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-20 (2023)
Abstract Metabolic reprogramming in cancer and immune cells occurs to support their increasing energy needs in biological tissues. Here we propose Single Cell Spatially resolved Metabolic (scSpaMet) framework for joint protein-metabolite profiling of
Externí odkaz:
https://doaj.org/article/005c3c264bfd4983a199d821ea1bd797
Autor:
Stein Hallan, Maryam Afkarian, Leila R. Zelnick, Bryan Kestenbaum, Shoba Sharma, Rintaro Saito, Manjula Darshi, Gregory Barding, Daniel Raftery, Wenjun Ju, Matthias Kretzler, Kumar Sharma, Ian H. de Boer
Publikováno v:
EBioMedicine, Vol 26, Iss C, Pp 68-77 (2017)
Chronic kidney disease (CKD) is a public health problem with very high prevalence and mortality. Yet, there is a paucity of effective treatment options, partly due to insufficient knowledge of underlying pathophysiology. We combined metabolomics (GCM
Externí odkaz:
https://doaj.org/article/a4d0f131e2714adf87397a4be51fc2bb
Autor:
Maryam Afkarian
Publikováno v:
American Journal of Kidney Diseases. 81:728-731
Autor:
Ayano Kondo, Monee McGrady, Dhiraj Nallapothula, Hira Ali, Alexandro E. Trevino, Amy Lam, Ryan Preska, H. Blaize D’Angio, Zhenqin Wu, Lauren Lopez, Harshanna Kaur Badhesha, Chenoa Rochel Vargas, Achyuta Ramesh, Nasim Wiegley, Seung Seok Han, Marc Dall’Era, Kuang-Yu Jen, Aaron T. Mayer, Maryam Afkarian
Aims/HypothesisDiabetic kidney disease (DKD) remains a significant cause of morbidity and mortality in people with diabetes. Though animal models have taught us much about the molecular mechanisms of DKD, translating these findings to human disease r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7cbc886ec46791369929a21d929de6b
https://doi.org/10.1101/2023.04.12.534028
https://doi.org/10.1101/2023.04.12.534028
Autor:
Karen Matsukuma, Benjamin Spencer, Shuai Chen, Xiaolu Situ, Maryam Afkarian, Guobao Wang, Souvik Sarkar, Michael T. Corwin
Publikováno v:
Metabolic syndrome and related disorders, vol 19, iss 9
Metab Syndr Relat Disord
Metab Syndr Relat Disord
BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a severe form of fatty liver disease that has been shown to be associated with chronic kidney disease (CKD). Mechanism for the association of NASH with CKD remains unclear. In this study, we examined
Publikováno v:
Pediatric nephrology (Berlin, Germany), vol 37, iss 11
Diabetic kidney disease (DKD), previously encountered predominantly in adult patients, is rapidly gaining center stage as a childhood morbidity and one that pediatric nephrologists are likely to encounter with increasing frequency. This is in large p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47fee9456c420e021c513e8a45b79b63
https://escholarship.org/uc/item/6vt482g8
https://escholarship.org/uc/item/6vt482g8
Publikováno v:
Cellular and Molecular Life Sciences. 79
Diabetic nephropathy (DN) is a significant complication of diabetes and the leading cause of end-stage renal disease. Hyperglycemia-induced dysfunction of the glomerular podocytes is a major contributor to the deterioration of renal function in DN. P
Autor:
J. S. Haw, Michael Mauer, Janet B. McGill, Jill P. Crandall, Bruce A. Perkins, Ruth S. Weinstock, Katherine R. Tuttle, Afshin Parsa, Tom Elliott, Peter Rossing, Amy B. Karger, Amisha Wallia, Cathie Spino, Mark E. Molitch, I. H. de Boer, Maryam Afkarian, David Z.I. Cherney, Sylvia E. Rosas, Irl B. Hirsch, Sarit Polsky, Allison B. Goldfine, Andrzej T. Galecki, Guillermo E. Umpierrez, Ronald J. Sigal, Marlon Pragnell, Ildiko Lingvay, M. L. Caramori, Rodica Pop-Busui, Ronnie Aronson, William N. Robiner, Chun Yi Wu, David M. Maahs, Peter A. Senior, Alessandro Doria
Publikováno v:
N Engl J Med
BACKGROUND: Higher serum urate levels are associated with an increased risk of diabetic kidney disease. Lowering of the serum urate level with allopurinol may slow the decrease in the glomerular filtration rate (GFR) in persons with type 1 diabetes a
Autor:
Amisha Wallia, Irl B. Hirsch, Afshin Parsa, Alessandro Doria, J. Sonya Haw, Catherine Spino, Bruce A. Perkins, Amy B. Karger, Peter Rossing, Katherine R. Tuttle, Andrzej T. Galecki, Ruth S. Weinstock, Rodica Pop-Busui, Sylvia E. Rosas, Guillermo E. Umpierrez, Ronald J. Sigal, David M. Maahs, Ildiko Lingvay, Janet B. McGill, Maryam Afkarian, Jill P. Crandall, Mark E. Molitch, Ronnie Aronson, Peter A. Senior, Allison B. Goldfine, Sarit Polsky, Michael Mauer, Maria Luiza Caramori, David Z.I. Cherney, Chun Yi Wu, Ian H. de Boer, Marlon Pragnell, Tom Elliott
Publikováno v:
Diabetes Care
OBJECTIVE Higher serum uric acid (SUA) is associated with diabetic kidney disease (DKD). Preventing Early Renal Loss in Diabetes (PERL) evaluates whether lowering SUA with allopurinol slows glomerular filtration rate (GFR) loss in people with type 1
Autor:
Katherine A Sauder, Jeanette M Stafford, Elizabeth J Mayer-Davis, Elizabeth T Jensen, Sharon Saydah, Amy Mottl, Lawrence M Dolan, Richard F Hamman, Jean M Lawrence, Catherine Pihoker, Santica Marcovina, Ralph B D'Agostino, Dana Dabelea, Maryam Afkarian, James Amrhein, Natalie Beauregard, Ronny Bell, Anna Bellatorre, Clifford A. Bloch, Deborah Bowlby, Ralph D'Agostino, Stephen Daniels, Jasmin Divers, Lawrence M. Dolan, Vinod P. Gaur, Maureen T. Goldstein, Carla Greenbaum, Richard F. Hamman, Jessica Harting, Leora Henkin, Irl Hirsch, Kim Holmquist, Giuseppina Imperatore, Scott Isom, Malaka Jackson, Michael G. Kahn, Sue Kearns, Grace Kim, Georgeanna J. Klingensmith, Mary Klingsheim, Lisa Knight, Corinna Koebnick, Jean M. Lawrence, Xia Li, Angela D. Liese, Barbara Linder, Lenna L. Liu, Beth Loots, Kathy Love-Osborne, David Maahs, Santica M. Marcovina, Elizabeth J. Mayer-Davis, Anwar Merchant, Lina Merjaneh, Timothy Morgan, Debika Nandi-Munshi, John Neff, Bryce Nelson, Michael Pascual, David J. Pettitt, June Pierce, Jeffrey Powell, Beth Reboussin, Marian J. Rewers, Kristi Reynolds, Sharon H. Saydah, Jeanette Stafford, Debra A. Standiford, Greg Strylewicz, Craig Taplin, Lisa Testaverde, Joan Thomas, Paul Wadwa, Lynne E. Wagenknecht, Greta Wilkening, Carrie Williams, Davene Wright, Joyce Yi-Frazier
Publikováno v:
The Lancet Child & Adolescent Health. 3:35-43
Summary Background One in three adolescents and young adults with type 1 diabetes have at least one early diabetes-related complication or comorbidity. We aimed to examine the prevalence and pattern of co-occurring complications in this population, a